Photo:
m4rd.org
Apr 13, 2026, 13:02
CAN-ACT Reaches 200 Patients in Six Months – Loeys-Dietz Syndrome Foundation Canada
Loeys-Dietz Syndrome Foundation Canada shared a post on LinkedIn:
“Milestone achieved: 200 patients enrolled in just six months!!
This important achievement reflects the growing momentum of the Canadian Aortopathy and Connective Tissue Disorders Registry (CAN-ACT), a national initiative advancing research on heritable syndromic aortopathies across Canada.
By integrating clinical, genetic, and quality-of-life data, CAN-ACT is helping drive earlier diagnosis, improved care, and stronger advocacy for these rare conditions.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies